全文获取类型
收费全文 | 61153篇 |
免费 | 5280篇 |
国内免费 | 3601篇 |
专业分类
耳鼻咽喉 | 605篇 |
儿科学 | 719篇 |
妇产科学 | 587篇 |
基础医学 | 7225篇 |
口腔科学 | 941篇 |
临床医学 | 7149篇 |
内科学 | 10203篇 |
皮肤病学 | 774篇 |
神经病学 | 3524篇 |
特种医学 | 2926篇 |
外国民族医学 | 19篇 |
外科学 | 6631篇 |
综合类 | 8900篇 |
现状与发展 | 14篇 |
一般理论 | 7篇 |
预防医学 | 3685篇 |
眼科学 | 1441篇 |
药学 | 6465篇 |
51篇 | |
中国医学 | 2915篇 |
肿瘤学 | 5253篇 |
出版年
2024年 | 163篇 |
2023年 | 813篇 |
2022年 | 2105篇 |
2021年 | 2905篇 |
2020年 | 2086篇 |
2019年 | 1905篇 |
2018年 | 1995篇 |
2017年 | 1831篇 |
2016年 | 1991篇 |
2015年 | 2862篇 |
2014年 | 3408篇 |
2013年 | 3433篇 |
2012年 | 4930篇 |
2011年 | 5216篇 |
2010年 | 3734篇 |
2009年 | 2831篇 |
2008年 | 3554篇 |
2007年 | 3495篇 |
2006年 | 3153篇 |
2005年 | 3077篇 |
2004年 | 2273篇 |
2003年 | 2321篇 |
2002年 | 1941篇 |
2001年 | 1448篇 |
2000年 | 1157篇 |
1999年 | 1067篇 |
1998年 | 624篇 |
1997年 | 595篇 |
1996年 | 402篇 |
1995年 | 460篇 |
1994年 | 321篇 |
1993年 | 198篇 |
1992年 | 302篇 |
1991年 | 229篇 |
1990年 | 194篇 |
1989年 | 199篇 |
1988年 | 138篇 |
1987年 | 147篇 |
1986年 | 134篇 |
1985年 | 81篇 |
1984年 | 52篇 |
1983年 | 32篇 |
1982年 | 30篇 |
1981年 | 22篇 |
1980年 | 21篇 |
1979年 | 23篇 |
1974年 | 14篇 |
1973年 | 20篇 |
1972年 | 12篇 |
1969年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
B J Dong 《American journal of hospital pharmacy》1990,47(2):356-361
The patient-care activities of a pharmacist in a thyroid clinic are described. Since 1978 a pharmacist has been an active member of the staff of a thyroid clinic associated with a 500-bed university hospital. More than 1500 patients are referred to the clinic each year. The pharmacist initiates, maintains, or modifies the drug therapy of selected patients with physician-diagnosed thyroid disorders under the guidance of written protocols approved by the chief endocrinologist. Most patients treated by the pharmacist are receiving thyroid-suppression therapy, antithyroid drugs for Graves' disease, or thyroid hormone supplementation after surgery or after radioactive iodine therapy. The pharmacist assesses patients, prescribes medications, orders laboratory tests, charts visits and therapeutic plans, and educates patients about their conditions. Major changes in thyroid status and drug therapy are always discussed with the chief endocrinologist. The pharmacist also participates in educational programs to influence prescribing by physicians, provides drug information, serves as a preceptor to pharmacy students, and is investigating the equivalence of levothyroxine preparations in vivo and in vitro. An audit of patient outcomes showed that the pharmacist is highly effective in her role as a giver of direct patient care. A pharmacist's role in a thyroid clinic can consist of clinical practice, education, preceptorship, and research. 相似文献
32.
胃癌D17S261和D17S799位点二核苷酸重复序列不稳定性的意义 总被引:2,自引:2,他引:0
目的研究二核苷酸重复序列不稳定性〔DRSI〕在胃癌发生中的作用及其临床意义.方法采用PCR方法检测了D17S261和D17S799位点二核苷酸重复序列不稳定性.结果胃癌总DRSI发生率为34%(17/50),其中高中分化腺癌DRSI阳性率(667%,10/15)显著高于低分化癌(194%,6/31,P<001);肠型胃癌DRSI阳性率(556%,10/18)显著高于胃型胃癌(20%,6/30,P<005),DRSI与胃癌部位、大小、浸润、分期、淋巴结转移无显著相关.结论DRSI在胃癌的发生中可能起重要作用. 相似文献
33.
Hea-Young P. Choo Hea-Ran Yoon Hwha-Soon Park Dong-Hyun Kim Jongsei Park Dong H. Kim 《Archives of pharmacal research》1998,21(2):168-173
The epoxyalkanoyl derivatives were designed and synthesized as ACE inhibitors. Coupling of unsaturated carboxylic acids with amino acids and following epoxidation with dimethyldioxirane gave the epoxyalkanoyls with high yield. The inhibitory activity of synthesized compounds on angiotensin converting enzyme was IC50 values of 0.06≈5.5 μM. 相似文献
34.
35.
传统腺样体切除术后腺样体残留情况调查 总被引:39,自引:0,他引:39
体统的腺样体手术为腺样体刮除术,为非直视下的手术,虽然多数患者手术后症状得得缓解,但临床上也常常看到手术后短时间内症状复发或者缓解不彻底的患儿,这类情况往往和腺样体手术切除不彻底有关。本院自2003年1月-2004年9月间对腺样体切除术后复发再次手术患者,以鼻内镜观察记录腺样体残留情况,对初次手术患者在进行传统腺样体刮除术并止血后,立即进行鼻内镜检查,了解腺样体残留情况并进行鼻内镜下处理,报告如下。 相似文献
36.
Zhong Rui-kun钟瑞琨 Dong Yong-he董永和and Lu Dao-pei陆道培Institute of Hematology Beijing Medical University Beijing 《中华医学杂志(英文版)》1989,102(7):537-544
In order to understand the mechanism of immunosuppression caused by infusion of placental gamma globulin (PGG) in patients with renal allografts, rheumatoid arthritis, and graft – versus –host disease (GCHD) following bone marrow transplantation (BMT) ,we have examined the effect of PGG in vitro and in a model of the xenogeneic , local graft –ver- sus – host reaction (LGVHR) .PGG inhibited lymphocyte proliferation in mixed lymphocyte cultures (MLC) (P<0.005) and depressed interleukin -2 (IL-2) levels in such cultures at 72 hours (P<0.01) . In contrast phytohemagglutinin (PHA) –and pokeweed mitogen (PWM) –induced T and B lymphocyte blastogenesis was not affected by such PGG treatment .PGG treatment .PGG neither decreased the [3H] TdR pulse incorporation in unstimulated lymphocytes nor affected cell viability .Cell cycle analysis by flow cytometry showed that PGG reduced the percentage of cells in S and G2, M phases during the MLC, but did not alter cell cycling during PWM-stimulated proliferation .
An immunosuppressive effect of PGG on the LGCHR was tested in a model of intracutaneous transplantation of PGG –treat human lymphocytes into cyclophosphamide – immunosuppressed rats. Lymphoprep – separated human tonsillar lymphocytes were incubated with RPMI-1640 buffer containing:(1)PGG,4mg/ml,(2) human plasma albumin,4mg/ml,(3)mitomycin-C,25ug/ml, or (4) no additive. Cell of each preparation (3x107cells in 0.1ml) were injected intracutaneously into cyclophosphamide-treated male rats at separate abdominal locations. A fifth site received only the buffer solution. Five days after injection of cells ,each rat received [125 I]IUdR (10uCi) intraperitoneally and was killed after 5 hours. For each site of injection, the diameters of induration were measured and 125 I was counted . There was no difference between buffer – treated and a ibumin – treated groups either in the diameter of the area of induration (t=0.66;P>0.5)or in radioactive counts(t=0.22;P>0.05).In the PGG –treated group, the induration and radioactivity measurements were significantly less than in control groups (t=3.72 and P<0.1;t=2.62 and P<0.02,respectively ) Cytophilic antibodies in PGG were thought to inhibit an early phase of T cell activation, and not to be cytotoxicity .In the LGVHR, the immune response might be abrogated either by immuno- regulatory suppression of T cell function or by toxicity to the infused lymphoid cells. For some clinical purposes, immuno- modulating, human antibodies might be preferred to murine, monoclonal antibodies. 相似文献
37.
38.
使用N-甲基吗啉-N-氧化物的水合物(NMMO·H2O)作为再生丝素的溶剂.可以得到w=0.10~0.25的再生丝素/NMMO·H2O溶液.研究了再生丝素/NMMO·H2O溶液流变性能,讨论了剪切速率、温度和溶液中的再生丝素的含量对再生丝素/NMMO·H2O溶液流变性能的影响. 相似文献
39.
Ⅰ、Ⅲ型前胶原基因第2外显子核酶对靶RNA的体外切割活性的研究 总被引:5,自引:0,他引:5
目的 体外研究锤头型α1Ⅰ型及Ⅲ型前胶原基因第2外显子片段核酶对各自靶RNA分子的切割活性及反应条件。同时观察两反义核酶对瘢痕中成纤维细胞胶原合成的影响。方法 将含α1Ⅰ型及Ⅲ型前胶原基因第2外显子片段的重组质粒(pT-Ⅰ、pT-Ⅲ),经体外^32P标记转录后形成产物靶RNA。同时将含特异性核酶基因的重组质粒(pT-gⅠ、pT-gⅢ)进行非标记的体外转录,产物(核酶)与各自的^32P-靶RNA按不同的条件混和反应,电泳后放射自显影观察结果。将构建好的核酶以脂质体包裹后导入培养的成纤维细胞内,采用图像分析法观察核酶对成纤维细胞Ⅰ型、Ⅲ型胶原蛋白mRNA合成的影响。结果 两种核酶在37℃、42℃均能有效切割各自的靶RNA,对Mg^2 浓度的要求范围较宽(10~20mmol/L);反应温度从65℃逐渐降至并维持在37℃的条件下核酶切割活性显提高。Ⅰ、Ⅲ型胶原蛋白mRNA的表达明显降低,胶原蛋白生成降低,胶原生成明显受抑制。结论 针对α1Ⅰ型及Ⅲ型前胶原基因第2外显子片段的核酶能有效地在体外对靶RNA进行切割并能有效地抑制瘢痕中成纤维细胞胶原的合成。 相似文献
40.
In-situ forming drug delivery systems are prepared by dissolving a drug and a biodegradable polymer (poly(D,L-lactide-co-glycolide), PLGA) in a biocompatible organic solvent (In-situ implant, ISI) or further emulsified into an external phase (oil or aqueous solution), resulting in oil-in-oil or oil-in-water emulsions (In-situ forming microparticles, ISM). The chemical stability of PLGA and the drug is a major concern. In this study, the stability of PLGA and leuprolide acetate in the in-situ forming systems and lyophilized sponges was investigated. The degradation of PLGA increased with increasing storage temperature and water content in the biocompatible solvents. A faster degradation occurred in polar protic solvents (2-pyrrolidone, PEG 400, triethyl citrate) than in polar aprotic solvents (N-methyl-2-pyrrolidone, DMSO, triacetin, ethyl acetate). The presence of leuprolide acetate significantly accelerated PLGA degradation, especially in solution state. PLGA was stable in oily suspensions at 4 degrees C and degraded only slightly faster than solid powder at 25 degrees C. No interaction between the oils and the PLGA was observed as indicated by an unchanged T(g) of approx. 47 degrees C. PLGA underwent a slight degradation at 4 degrees C after 150 days in water and saturated sodium chloride solution. The degradation was slower in saturated sodium chloride solution than in water at 25 degrees C. Residual acetic acid in lyophilized sponges facilitated the PLGA degradation in contrast to dioxane. Leuprolide acetate did not affect the PLGA stability negatively. However, lidocaine significantly enhanced the polymer degradation in the sponges. Finally, leuprolide acetate was chemically stable in the sponges, the oils and the polymer solutions in suspension state, but unstable (aggregation) when dissolved in the polymer solutions and stored at 25 degrees C and 40 degrees C. 相似文献